These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 28401585)
1. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index. Dirschka T; Pellacani G; Micali G; Malvehy J; Stratigos AJ; Casari A; Schmitz L; Gupta G; J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1295-1302. PubMed ID: 28401585 [TBL] [Abstract][Full Text] [Related]
2. Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma. Schmitz L; Gambichler T; Gupta G; Stücker M; Dirschka T J Eur Acad Dermatol Venereol; 2018 May; 32(5):752-756. PubMed ID: 29117441 [TBL] [Abstract][Full Text] [Related]
3. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI). Jordan M; Ghoreschi K; Eberle FC Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943 [TBL] [Abstract][Full Text] [Related]
4. Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index. Schmitz L; Gupta G; Segert MH; Kost R; Sternberg J; Gambichler T; Stockfleth E; Dirschka T Skin Pharmacol Physiol; 2018; 31(4):206-211. PubMed ID: 29791916 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI). Schmitz L; von Dobbeler C; Gupta G; Gambichler T; Szeimies RM; Morton CA; Dirschka T Photodiagnosis Photodyn Ther; 2018 Mar; 21():66-70. PubMed ID: 29051122 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Actinic Keratosis and Severity Index with Physician Global Assessment and Total Lesion Count and the Ability to Predict Skin Cancer. Acar A; Karaarslan I Dermatol Pract Concept; 2022 Feb; 12(1):e2022031. PubMed ID: 35223175 [TBL] [Abstract][Full Text] [Related]
7. Actinic keratosis area and severity index is not correlated with photodynamic therapy procedural pain. Sharma A; Vincent L Photodiagnosis Photodyn Ther; 2020 Sep; 31():101946. PubMed ID: 32795507 [TBL] [Abstract][Full Text] [Related]
8. A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity. Dréno B; Cerio R; Dirschka T; Nart IF; Lear JT; Peris K; de Casas AR; Kaleci S; Pellacani G Acta Derm Venereol; 2017 Oct; 97(9):1108-1113. PubMed ID: 28536731 [TBL] [Abstract][Full Text] [Related]
9. Actinic Keratosis Area Severity Index (AKASI): reproducibility study and comparison with total lesion count. Pellacani G; Gupta G; Micali G; Malvehy J; Stratigos AJ; Casari A; Chester J; Kaleci S; Dirschka T Br J Dermatol; 2018 Sep; 179(3):763-764. PubMed ID: 29572818 [No Abstract] [Full Text] [Related]
10. Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study. Kirchberger MC; Gfesser M; Erdmann M; Schliep S; Berking C; Heppt MV J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510952 [TBL] [Abstract][Full Text] [Related]
11. Association between calcium channel blockers and the severity of actinic keratosis on face and scalp: a cross-sectional study. Gioppo IS; de Castro Martins IM; Santos SS; Preto JFR; Miola AC; Miot HA Int J Dermatol; 2023 Dec; 62(12):1511-1519. PubMed ID: 37855160 [TBL] [Abstract][Full Text] [Related]
12. Vascular feature identification in actinic keratosis grades I-III using dynamic optical coherence tomography with automated, quantitative analysis. Fredman G; Wiegell SR; Haedersdal M; Untracht GR Arch Dermatol Res; 2024 Jun; 316(7):391. PubMed ID: 38878217 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial. Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282 [TBL] [Abstract][Full Text] [Related]
14. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415 [TBL] [Abstract][Full Text] [Related]
15. MAL Daylight Photodynamic Therapy for Actinic Keratosis: Clinical and Imaging Evaluation by 3D Camera. Cantisani C; Paolino G; Pellacani G; Didona D; Scarno M; Faina V; Gobello T; Calvieri S Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409613 [TBL] [Abstract][Full Text] [Related]
16. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis. Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Actinic Keratosis in Patients Attending General Practitioners in Switzerland. Dziunycz PJ; Schuller E; Hofbauer GFL Dermatology; 2018; 234(5-6):214-219. PubMed ID: 30125890 [TBL] [Abstract][Full Text] [Related]
18. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma. Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269 [TBL] [Abstract][Full Text] [Related]